Where does EBT Medical, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), EBT Medical, Inc. ranks #14,582 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does EBT Medical, Inc. hold?

EBT Medical, Inc. holds 20 US utility patents granted between 2019 and 2025, spanning 4 technology areas.

What is EBT Medical, Inc.'s Innovation Score?

EBT Medical, Inc. has an Innovation Score of 40.4 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does EBT Medical, Inc. focus on?

EBT Medical, Inc.'s top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 19 patents, ranking #194 of 1,943 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is EBT Medical, Inc.'s patent grant rate increasing or decreasing?

EBT Medical, Inc.'s recent grant velocity is +1500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for EBT Medical, Inc.'s patents?

EBT Medical, Inc.'s patents average 22.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the EBT Medical, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

EBT Medical, Inc.

USPTO PatentsView assignee record - 20 granted patents across 4 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, EBT ranks #14,582 of 49,997 tracked US assignees by granted-patent volume, with 20 patents across 4 technology areas.

#14,582
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.4/100): 22.1
avg claims per patent: +1500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14582 · Foreign Corporation #14,582 · 20 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 20 grants
MID-PACK #14,582/49,997
PHOTO-FINISH Douglas Dynamics L L C
CPC-NARROW A61N · 4 areas
INNOV-PAR 40.4/100
CLAIMS-DENSE 22.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +1500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Douglas Dynamics, L.L.C. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How EBT’s 40.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.5 pts (26%) Velocity 9.5 pts (24%) Breadth 7.1 pts (18%) Claim depth 13.3 pts (33%)

Qualcomm Incorporated · highest

85
EBT Medical · this assignee

40
3D Lighting… · lowest

7

What this shows EBT's Innovation Score is 40.4/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for EBT?

Each dot is one of EBT’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). EBT’s own 22.1 claims/patent is ABOVE the 16.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

EBT vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where EBT's grants concentrate

EBT Medical, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 95% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2022 (5 grants) versus a trough of 1 in 2019. By volume, EBT sits between Douglas Dynamics, L.L.C. and ES FiberVisions Co., Ltd..

EBT's three-year grant acceleration

EBT Medical, Inc. shows 10 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Douglas Dynamics…

20
Duality

20
Duerr Systems

20
E V Offshore

20
Elkem ASA

20
Eotech

20
Epic Systems

20
ES Fibervisions

20
EBT Medical ◀

20

What this shows EBT holds 20 patents at rank #14,581, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near EBT

By rank, the assignees closest to #14,581 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in EBT's primary technology class.

EBT's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

EBT Medical, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	5.0%
2020	4	20.0%
2021	2	10.0%
2022	5	25.0%
2023	2	10.0%
2024	3	15.0%
2025partial year	3	15.0%

Which technologies does EBT Medical, Inc. patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 19

A61B - DIAGNOSIS; SURGERY; Identification 2

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

EBT Medical, Inc.'s patent record in context - here's where to go next.

EBT Medical, Inc.'s lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 95% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #14,582 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare EBT Medical, Inc. against Douglas Dynamics, L.L.C., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.